ABOUT ZOGENIX

Where Medicine Meets Technology

Zogenix is a specialty pharmaceutical company whose goal is to uniquely enhance and differentiate medicines by incorporating innovative technologies in an effort to relieve suffering in people with CNS and pain disorders.

Founded in 2006, the company currently has two proprietary product candidates in late-stage development. Our lead product candidate, sumatriptan DosePro™, is a drug-device combination that enables needle-free delivery of subcutaneous sumatriptan – the fastest acting migraine medicine – for the treatment of migraine and cluster headache. Our second product candidate, ZX002, is a novel, oral controlled-release formulation of hydrocodone for the treatment of chronic pain.